The aim of this chapter is to introduce tools that we have specifically developed for PDM-2 assessment and to survey a broad range of empirically validated assessment tools that may enhance clinicians’ use of PDM-2 for diagnostic formulations, clinical reports, treatment planning, or research
Assessment within the PDM‑2 Framework / Waldron, Sherwood; Gordon, Robert M.; Gazzillo, Francesco; Abbass, Allan; Auerbach, John S.; Barber, Jacques; Blais, Mark; Bornstein, Robert F.; Bram, Anthony; Cierpka, Manfred; Clarkin, John F.; Del Corno, Franco; Dewitt, Kathryn; Diamond, Diana; Genova, Federica; George, Carol; Hilsenroth, Mark J.; Høglend, Per; Huprich, Steven K.; Josephs, Lawrence; Kächele, Horst; Klug, Guenther; Lambert, Michael J.; Luyten, Patrick; Leuzinger‑bohleber, Marianne; Moscovitz, Seymour; Norcross, John C.; Christopher Perry, J.; Porcerelli, John H.; Porcelli, Piero; Safran, Jeremy D.; Silberschatz, George; Speranza, Anna Maria; Stein, Michelle; Stiles, William; Stukenberg, Karl; Tanzilli, Annalisa. - STAMPA. - (2017), pp. 889-972.
Assessment within the PDM‑2 Framework
Francesco Gazzillo;Federica Genova;Anna Maria Speranza;Annalisa Tanzilli
2017
Abstract
The aim of this chapter is to introduce tools that we have specifically developed for PDM-2 assessment and to survey a broad range of empirically validated assessment tools that may enhance clinicians’ use of PDM-2 for diagnostic formulations, clinical reports, treatment planning, or researchFile | Dimensione | Formato | |
---|---|---|---|
Waldrom_Assessment_2017.pdf
solo gestori archivio
Tipologia:
Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
1.16 MB
Formato
Adobe PDF
|
1.16 MB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.